AVINGER INC (AVGR)
US0537348775 - Common Stock
We assign a fundamental rating of 2 out of 10 to AVGR. AVGR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of AVGR is average, but there are quite some concerns on its profitability. AVGR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AVGR had negative earnings in the past year.
AVGR had a negative operating cash flow in the past year.
AVGR had negative earnings in each of the past 5 years.
AVGR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
AVGR has a Return On Assets of -127.59%. This is amonst the worse of the industry: AVGR underperforms 88.24% of its industry peers.
AVGR's Return On Equity of -447.82% is on the low side compared to the rest of the industry. AVGR is outperformed by 86.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -127.59% | ||
| ROE | -447.82% | ||
| ROIC | N/A |
ROA(3y)-106.27%
ROA(5y)-96.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AVGR has a Gross Margin of 20.94%. This is amonst the worse of the industry: AVGR underperforms 80.21% of its industry peers.
AVGR's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AVGR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.94% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.35%
GM growth 5Y8.48%
2. Health
2.1 Basic Checks
AVGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVGR has more shares outstanding
AVGR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AVGR has a worse debt to assets ratio.
2.2 Solvency
AVGR has an Altman-Z score of -48.14. This is a bad value and indicates that AVGR is not financially healthy and even has some risk of bankruptcy.
AVGR's Altman-Z score of -48.14 is on the low side compared to the rest of the industry. AVGR is outperformed by 92.51% of its industry peers.
AVGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -48.14 |
ROIC/WACCN/A
WACC5.18%
2.3 Liquidity
AVGR has a Current Ratio of 1.21. This is a normal value and indicates that AVGR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AVGR (1.21) is worse than 86.10% of its industry peers.
A Quick Ratio of 0.81 indicates that AVGR may have some problems paying its short term obligations.
AVGR has a Quick ratio of 0.81. This is amonst the worse of the industry: AVGR underperforms 88.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
AVGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.40%, which is quite impressive.
Looking at the last year, AVGR shows a decrease in Revenue. The Revenue has decreased by -6.30% in the last year.
Measured over the past years, AVGR shows a decrease in Revenue. The Revenue has been decreasing by -0.69% on average per year.
EPS 1Y (TTM)66.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.67%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-4.41%
Revenue growth 5Y-0.69%
Sales Q2Q%-9.19%
3.2 Future
Based on estimates for the next years, AVGR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.51% on average per year.
AVGR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.27% yearly.
EPS Next Y-30.64%
EPS Next 2Y29.28%
EPS Next 3Y21.51%
EPS Next 5YN/A
Revenue Next Year-12.9%
Revenue Next 2Y29.82%
Revenue Next 3Y29.14%
Revenue Next 5Y27.27%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
AVGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AVGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as AVGR's earnings are expected to grow with 21.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.28%
EPS Next 3Y21.51%
5. Dividend
5.1 Amount
AVGR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVINGER INC
NASDAQ:AVGR (12/18/2024, 4:00:00 PM)
0.4903
-0.02 (-3.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.57M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -127.59% | ||
| ROE | -447.82% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.94% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)66.4%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-30.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-4.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y